logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (viii) All inpatient clients, primary drug distribution by age (%)

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Opioids10.527.250.064.968.665.262.244.91632243
Cocaine1.03.95.96.57.910.19.34.819466
Stimulants19.023.217.911.29.18.29.212.2364533
Hypnotics and sedatives6.72.02.52.53.35.47.022.1135915
Hallucinogens1.00.30.30.20.10.00.20.2510
Volatile substances30.55.61.00.70.60.50.40.23291
Cannabis 28.634.818.510.67.07.07.07.8363720
Other substances 2.92.93.93.53.53.64.77.811291
Total105225562267499522931041972202828418119

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, FR, CY, LV,HU, AT, RO, SK, FI, SE, UK, HR, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010